Hybridoma and monoclonal antibody MLS102 which recognizes a NeuAc alpha 2->6GalNAc sugar chain present on human intestinal cancer cells

摘要

The present invention relates to a monoclonal antibody MLS 102 recognizing human intestinal cancer cells, especially their sugar chain of glycoprotein, and more specifically NeuAc alpha 2->6GalNAc. The invention also relates to a hybridoma producing the monoclonal antibody which is prepared by fusing splenic cells of a mouse immunized by human intestinal cancer cells with myeloma cells.